Vitiligo
📧 Sign up to get email alerts when something new happens for Vitiligo.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo [Phase 2]
A Phase 2b dose-ranging study is evaluating the efficacy and safety of GIA632 for non-segmental vitiligo, with recruitment currently ongoing…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Comparative Study of Microneedling With Topical Minoxidil 5% ± NB-UVB in Stable Vitiligo" [Phase 2]
A Phase 2 clinical trial evaluating microneedling with topical minoxidil 5% with or without NB-UVB phototherapy for stable vitiligo; the stu…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Tyrosine Vs Tacrolimus With NB-UVB in Vitiligo [NA]
Clinical trial update describes a study comparing tyrosine versus tacrolimus with NB-UVB in vitiligo; the trial is currently active but not …
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Vitiligo Registry for Adults and Children in the UK
A UK vitiligo registry trial for adults and children, sponsored by The Royal Wolverhampton Hospitals NHS Trust, is currently not yet recruit…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Study of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in Vitiligo [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating umbilical cord mesenchymal stem cell-derived exosomes for vitiligo; the study is not yet recruit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study of Zasocitinib in Adults With Nonsegmental Vitiligo [Phase 2]
A Phase 2 clinical trial evaluating Zasocitinib in adults with nonsegmental vitiligo, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Comparative Efficacy of hUCMSC-Secretome Delivered Via Microneedling and Intradermal Microinjection as Adjuvant Therapy to NB-UVB in Nonsegmental Vitiligo: A Quasi-Experimental Study [Phase 2, Phase 3]
This clinical trial update outlines a Phase 2/Phase 3 quasi-experimental study assessing whether hUCMSC-secretome delivered by microneedling…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients [Phase 2]
Phase 2 study of EI-001 for non-segmental vitiligo is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2 [Phase 3]
Pfizer is conducting a 104-week Phase 3 study of Ritlecitinib oral capsules in adults with nonsegmental vitiligo (stable and active). The tr…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
This document summarizes an ongoing longitudinal observational study of patients undergoing therapy for IMISC (NCT03661866) across several i…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Combination Approach With Ritlecitinib and nbUVB Compared to Ritlecitinib Alone for Treating Vitiligo [Phase 2]
A Phase 2 clinical trial is evaluating the combination of ritlecitinib with nbUVB versus ritlecitinib alone for vitiligo, with recruitment n…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: The Value of Adding Mini-oral Pulse Steroid Therapy in Preventing Peri-lesional Halo Post Non-cultured Epidermal Cell Suspension (NCES) in Cases With Stable Segmental and Non-acral Vitiligo. [Phase 4]
Phase 4 clinical trial evaluating whether adding mini-oral pulse steroid therapy can prevent peri-lesional halo after non-cultured epidermal…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Daily Topical Rapamycin for Vitiligo [Phase 2]
Phase 2 trial evaluating daily topical rapamycin for vitiligo; the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: The Value of Methotrexate in NCES for Stable Vitiligo [Phase 4]
Ongoing Phase 4 clinical trial evaluating methotrexate for stable vitiligo at Cairo University; recruitment is currently ongoing.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Oral Mini Pulse Dexamethasone in Pediatric Vitiligo [Phase 4]
Phase 4 clinical trial investigating oral mini-pulse dexamethasone for pediatric vitiligo is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: A Trial of SHR0302 Tablets and SHR0302 Base Gel in Patients With Non-segmental Vitiligo [Phase 2]
A Phase 2 clinical trial is evaluating SHR0302 in non-segmental vitiligo, using both tablet and topical gel formulations, and is currently r…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Effectiveness of Micro-needling With 5 Fluorouracil Versus Potent Topical Steroids in the Treatment of Limited Vitiligo [EARLY_Phase 1]
A Phase 1 clinical trial update evaluating microneedling with 5-fluorouracil versus potent topical steroids for limited vitiligo, currently …
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa
A real-world, global study to assess disease burden in adolescents and adults with alopecia areata, vitiligo, or hidradenitis suppurativa.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: PALLAS Laser for Skin Diseases [NA]
A clinical trial update indicating recruitment for a study evaluating the PALLAS Laser for skin diseases, including vitiligo, psoriasis, alo…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo [Phase 1]
Phase 1 clinical trial evaluating the safety and potential efficacy of TEV-53408 for vitiligo, sponsored by Teva Branded Pharmaceutical Prod…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Comparison of Efficacy and Safety Psoralen Combined With Ultraviolet A (PUVA) Vs Tofacitinib in the Treatment of Generalized Vitiligo. [EARLY_Phase 1]
An early-phase 1, not-yet-recruiting clinical trial comparing PUVA therapy versus tofacitinib for generalized vitiligo, sponsored by Hayat A…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: A Proof of Concept, Phase 1 Study of CGB-600 for the Topical Treatment of Non-Segmented Facial Vitiligo [Phase 1]
This document provides a Phase 1 proof-of-concept trial update for CGB-600 as a topical treatment for vitiligo, and the study is currently r…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Nevus Removal vs. Conservative Treatment in Halo Nevus With Vitiligo: A Randomized Study [NA]
A randomized study compares nevus removal versus conservative treatment for halo nevus in patients with vitiligo; the trial is currently not…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Trial of SHR0302Base in Patients With Vitiligo [Phase 2]
Phase 2 clinical trial update for SHR-0302 in patients with vitiligo. The trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: LANDSCAPE: Demographics and Treatment Patterns of Patients With Immune-Mediated Inflammatory Skin Diseases in Italian Clinical Practice
The LANDSCAPE study, sponsored by Fondazione ISIDE, investigates demographics and treatment patterns of patients with immune-mediated inflam…